These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21505378)

  • 1. Posttransplant sCD30 as a predictor of kidney graft outcome.
    Süsal C; Döhler B; Sadeghi M; Salmela KT; Weimer R; Zeier M; Opelz G
    Transplantation; 2011 Jun; 91(12):1364-9. PubMed ID: 21505378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N; Aghdaie MH; Malekpour Z
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant sCD30 as a biomarker to predict kidney graft outcome.
    Süsal C; Opelz G
    Clin Chim Acta; 2012 Sep; 413(17-18):1350-3. PubMed ID: 22037199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
    Wang D; Wu W; Yang S; Wang Q; Tan J
    Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial soluble CD30 measurements as a predictor of kidney graft outcome.
    Halim MA; Al-Otaibi T; Al-Muzairai I; Mansour M; Tawab KA; Awadain WH; Balaha MA; Said T; Nair P; Nampoory MR
    Transplant Proc; 2010 Apr; 42(3):801-3. PubMed ID: 20430176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pre transplant T-cell activation status by soluble CD 30 determination.
    Abbas K; Muzaffar R; Zafar MN; Mubarak M; Naqvi SA; Rizvi SA
    J Pak Med Assoc; 2009 Apr; 59(4):212-5. PubMed ID: 19402280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
    Billing H; Sander A; Süsal C; Ovens J; Feneberg R; Höcker B; Vondrak K; Grenda R; Friman S; Milford DV; Lucan M; Opelz G; Tönshoff B
    Transpl Int; 2013 Mar; 26(3):331-8. PubMed ID: 23279372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W; Schlaf G; Rothhoff A; Seliger B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C; Bonnet MC; Perrat G; Houillon A; Reydet S; Pouteil-Noble C; Villar E; Lefrançois N; Morelon E; Dubois V
    Transplant Proc; 2007 Oct; 39(8):2574-5. PubMed ID: 17954178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
    Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
    Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30, a marker to detect the high-risk kidney transplant recipients.
    Spiridon C; Nikaein A; Lerman M; Hunt J; Dickerman R; Mack M
    Clin Transplant; 2008; 22(6):765-9. PubMed ID: 19040559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of soluble CD30 after kidney transplantation correlates with acute rejection episodes.
    Yang JL; Hao HJ; Zhang B; Liu YX; Chen S; Na YQ
    Transplant Proc; 2008 Dec; 40(10):3381-3. PubMed ID: 19100394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients.
    Spiridon C; Hunt J; Mack M; Rosenthal J; Anderson A; Eichhorn E; Magee M; Dewey T; Currier M; Nikaein A
    Transplant Proc; 2006 Dec; 38(10):3689-91. PubMed ID: 17175368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
    Hamer R; Roche L; Smillie D; Harmer A; Mitchell D; Molostvov G; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Briggs D; Lowe D; Zehnder D; Higgins R
    Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study.
    Delgado JC; Pavlov IY; Shihab FS
    Transpl Immunol; 2009 Dec; 22(1-2):1-4. PubMed ID: 19772921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation.
    Heinemann FM; Rebmann V; Witzke O; Philipp T; Broelsch CE; Grosse-Wilde H
    Transplantation; 2007 Mar; 83(6):706-11. PubMed ID: 17414702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
    Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.